
    
      122 subjects, operated on for Crohn disease, will be included in the study. After
      ileo-colonic resection, subjects will be randomized into two arms; they will be given either
      placebo or curcumin 3g/d per os plus thiopurines during 6 months in a double-blind manner.
      Rutggerts endoscopic score at 6 months will be the main judgment criteria.
    
  